Literature DB >> 5794063

Studies of uric acid pool size and turnover rate.

J T Scott, V P Holloway, H I Glass, R N Arnot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5794063      PMCID： PMC1010504          DOI： 10.1136/ard.28.4.366

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  The routine fitting of kinetic data to models: a mathematical formalism for digital computers.

Authors:  M BERMAN; E SHAHN; M F WEISS
Journal:  Biophys J       Date:  1962-05       Impact factor: 4.033

2.  Uric acid production in gout.

Authors:  J E SEEGMILLER; A I GRAYZEL; L LASTER; L LIDDLE
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

3.  The determination of creatinine in plasma or serum, and in urine; a critical examination.

Authors:  J A OWEN; B IGGO; F J SCANDRETT; C P STEWART
Journal:  Biochem J       Date:  1954-11       Impact factor: 3.857

4.  Recovery in humans of intravenously injected isotopic uric acid.

Authors:  J BUZARD; C BISHOP; J H TALBOTT
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

5.  Pool size, turnover rate, and rapidity of equilibration of injected isotopic uric acid in normal and pathological subjects.

Authors:  C BISHOP; W GARNER; J H TALBOTT
Journal:  J Clin Invest       Date:  1951-08       Impact factor: 14.808

6.  The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid.

Authors:  J D BENEDICT; P H FORSHAM; D STETTEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

7.  The interpretation of radioactive uric acid turnover data.

Authors:  H I Glass; J T Scott; D C Gilles; R N Arnot; V P Holloway; S S Ben Hameid
Journal:  Strahlentherapie Sonderb       Date:  1968

8.  Hypertension and hyperuricaemia.

Authors:  A Breckenridge
Journal:  Lancet       Date:  1966-01-01       Impact factor: 79.321
  8 in total
  8 in total

Review 1.  How neutrophil extracellular traps orchestrate the local immune response in gout.

Authors:  Christian Maueröder; Deborah Kienhöfer; Jonas Hahn; Christine Schauer; Bernhard Manger; Georg Schett; Martin Herrmann; Markus H Hoffmann
Journal:  J Mol Med (Berl)       Date:  2015-05-24       Impact factor: 4.599

2.  Plasma lipid levels in gout.

Authors:  L G Darlington; J T Scott
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

3.  Clinical survey of 354 patients with gout.

Authors:  R Grahame; J T Scott
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

4.  Causes of hyperuricaemia.

Authors:  J T Scott
Journal:  Proc R Soc Med       Date:  1969-08

5.  Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.

Authors:  Reza Khosravan; Brian A Grabowski; Jing-Tao Wu; Nancy Joseph-Ridge; Laurent Vernillet
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout.

Authors:  Nicola Dalbeth; Meaghan E House; Anne Horne; William J Taylor
Journal:  BMC Musculoskelet Disord       Date:  2013-12-21       Impact factor: 2.362

Review 7.  Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Xuemei Liu; Tingting Zhai; Ruixia Ma; Congjuan Luo; Huifang Wang; Liqiu Liu
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

8.  Pharmacokinetic/pharmacodynamic modeling and simulation of dotinurad, a novel uricosuric agent, in healthy volunteers.

Authors:  Keisuke Motoki; Takako Igarashi; Koichi Omura; Hiroshi Nakatani; Takashi Iwanaga; Ikumi Tamai; Tetsuo Ohashi
Journal:  Pharmacol Res Perspect       Date:  2019-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.